The «Grindeks» active pharmaceutical ingredients plant covers an area of approximately 10,000 m2. At this plant, high-quality active pharmaceutical ingredients are produced in reactors of various volumes (from 100 to 6,000 litres) for both the «Grindeks» final dosage forms plant and for export to clients abroad.
Due to targeted investments over the past few years in the modernisation and expansion of the «Grindeks» Active pharmaceutical ingredients manufacturing unit, the Company has secured a rapid increase in the volume of production. The volume of production has doubled over the last four years. The current maximum capacity of the production of active pharmaceutical ingredients is 200 tons a year.
In 2010, supplies to the «Grindeks» final dosage forms plant exceeded 90 tons of active pharmaceutical ingredients, and 15 tons of substances were manufactured for export.
«Grindeks» has all the necessary resources to ensure contract research and contract manufacturing of active pharmaceutical ingredients. The advanced Analytical Scale-up Laboratory completed in 2007 not only provides new opportunities for research of new products, but also opens a new niche for the manufacturing of products in small batches.
«Grindeks» is constantly investing in modernisation of technological potential and in increase of production capacity, introducing new and environmentally friendly technologies. Reconstruction of facilities and installation of new equipment makes it possible for the company to introduce new active pharmaceutical ingredients quicker, more succesfully and in line with the highest possible standarts.